Lisa Hays
Endocrinology, Diabetes & Metabolism · Merriam, KSNPI 1750450995
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,446 and has fallen 92.0% since, to $116 in 2025.
Across 222 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$652
- Novo Nordisk$529
- AstraZeneca$353
- Amgen$260
- Amarin Pharma, Inc.$224
- Pfizer$189
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,621100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 42 | $652 |
| Novo Nordisk | 46 | $529 |
| AstraZeneca(2 entities) | 17 | $353 |
| Amgen(2 entities) | 9 | $260 |
| Amarin Pharma, Inc. | 16 | $224 |
| Pfizer | 12 | $189 |
| Sanofi-aventis U.S. LLC | 13 | $173 |
| Boehringer Ingelheim | 10 | $161 |
| Radius Health, Inc. | 3 | $155 |
| AbbVie | 9 | $138 |
| Astellas Pharma US Inc | 5 | $116 |
| Tandem Diabetes Care, Inc. | 3 | $88 |
| Medtronic(2 entities) | 4 | $76 |
| Insulet Corporation | 3 | $71 |
| Merck | 5 | $65 |
| Dexcom, Inc. | 4 | $61 |
| IBSA Pharma Inc. | 3 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Amneal Pharmaceuticals LLC | 3 | $40 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $24 |
| Shire North American Group Inc | 1 | $18 |
| Companion Medical, Inc. | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $15 |
| Vivus LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| UCB, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,635 in reported general payments places this provider in the 65th percentile of 50 endocrinology, diabetes & metabolism providers in Kansas.
See all endocrinology, diabetes & metabolism providers in Kansas →
Other endocrinology, diabetes & metabolism in Merriam
- Nichole SmithMerriam$9K
- Sabah PatelMerriam$904
- Dany ZayourWichita$744K
- Andrew GreenShawnee Mission$322K
- Michael SokolOverland Park$227K
- Rami MortadaWichita$105K
- Sajeev MenonOverland Park$25K
- Georges ElhomsyWichita$14K
- Richard GomendozaSalina$13K
- John MilesKansas City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.